1. Home
  2. GLMD vs AREB Comparison

GLMD vs AREB Comparison

Compare GLMD & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • AREB
  • Stock Information
  • Founded
  • GLMD 2000
  • AREB 2014
  • Country
  • GLMD Israel
  • AREB United States
  • Employees
  • GLMD N/A
  • AREB N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • GLMD Health Care
  • AREB Industrials
  • Exchange
  • GLMD Nasdaq
  • AREB Nasdaq
  • Market Cap
  • GLMD 7.9M
  • AREB 8.4M
  • IPO Year
  • GLMD 2014
  • AREB N/A
  • Fundamental
  • Price
  • GLMD $1.49
  • AREB $1.16
  • Analyst Decision
  • GLMD Hold
  • AREB
  • Analyst Count
  • GLMD 1
  • AREB 0
  • Target Price
  • GLMD N/A
  • AREB N/A
  • AVG Volume (30 Days)
  • GLMD 164.0K
  • AREB 252.1K
  • Earning Date
  • GLMD 09-02-2025
  • AREB 08-12-2025
  • Dividend Yield
  • GLMD N/A
  • AREB N/A
  • EPS Growth
  • GLMD N/A
  • AREB N/A
  • EPS
  • GLMD N/A
  • AREB N/A
  • Revenue
  • GLMD N/A
  • AREB $9,474,958.00
  • Revenue This Year
  • GLMD N/A
  • AREB N/A
  • Revenue Next Year
  • GLMD N/A
  • AREB N/A
  • P/E Ratio
  • GLMD N/A
  • AREB N/A
  • Revenue Growth
  • GLMD N/A
  • AREB N/A
  • 52 Week Low
  • GLMD $1.15
  • AREB $1.02
  • 52 Week High
  • GLMD $23.80
  • AREB $193.48
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 44.36
  • AREB 39.53
  • Support Level
  • GLMD $1.35
  • AREB $1.02
  • Resistance Level
  • GLMD $1.59
  • AREB $1.37
  • Average True Range (ATR)
  • GLMD 0.11
  • AREB 0.10
  • MACD
  • GLMD 0.00
  • AREB 0.00
  • Stochastic Oscillator
  • GLMD 44.56
  • AREB 40.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: